Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells ...
Le Lézard16h
MEXC to List StakeStone (STO) to Support Omnichain Liquidity Innovation with 130,000 USDT Airdrop+ Rewards
MEXC, a leading global cryptocurrency exchange, is excited to announce that it has listed StakeStone (STO) on both the spot ...
Le Lézard16h
Trevi Therapeutics to Participate in Upcoming April Investor Conferences
Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...